Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Viking Therapeutics, Inc. (VKTX), most recent 12 months reported: revenue $0, net loss $534.8M. Latest balance sheet on file: liquid cash $501.66M. From SEC filings. More on Viking Therapeutics, Inc.: Revenue · Profitability · Debt Others in Pharmaceutical Preparations: UNICYCIVE THERAPEUTICS, INC. · Valion Bio, Inc. · Vera Therapeutics, Inc. · VERU INC. · WHITEHAWK THERAPEUTICS, INC. · XBiotech Inc. · EXICURE, INC. · XENON PHARMACEUTICALS INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.